BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38536847)

  • 41. Ceftriaxone use in brucellosis: A case series.
    Fatani DF; Alsanoosi WA; Badawi MA; Thabit AK
    IDCases; 2019; 18():e00633. PubMed ID: 31534908
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Osteoarticular involvement in brucellosis: study of 196 cases in the Republic of Macedonia.
    Bosilkovski M; Krteva L; Caparoska S; Dimzova M
    Croat Med J; 2004 Dec; 45(6):727-33. PubMed ID: 15578807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brucellosis: haemorrhagic pleural effusion.
    Al-Anazi AR; Aziz S; Fouda MA
    Med Princ Pract; 2005; 14(2):118-20. PubMed ID: 15785106
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Doxycycline-rifampin versus doxycycline-rifampin-gentamicin in treatment of human brucellosis.
    Mile B; Valerija K; Krsto G; Ivan V; Ilir D; Nikola L
    Trop Doct; 2012 Jan; 42(1):13-7. PubMed ID: 22290107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurobrucellosis.
    Gokul BN; Paul A; Hussein I
    Saudi Med J; 2000 Jun; 21(6):577-80. PubMed ID: 11500711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical, diagnostic and therapeutic approaches to complications of brucellosis: an experience of 12 years.
    Mermut G; Ozgenç O; Avcı M; Olut AI; Oktem E; Genç VE; Arı A; Coskuner SA
    Med Princ Pract; 2012; 21(1):46-50. PubMed ID: 22024559
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans.
    Hasanjani Roushan MR; Mohraz M; Hajiahmadi M; Ramzani A; Valayati AA
    Clin Infect Dis; 2006 Apr; 42(8):1075-80. PubMed ID: 16575723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The epidemiology of human brucellosis in a well defined urban population in Saudi Arabia.
    Cooper CW
    J Trop Med Hyg; 1991 Dec; 94(6):416-22. PubMed ID: 1758015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of two durations of triple-drug therapy in patients with uncomplicated brucellosis: A randomized controlled trial.
    Sofian M; Velayati AA; Aghakhani A; McFarland W; Farazi AA; Banifazl M; Eslamifar A; Ramezani A
    Scand J Infect Dis; 2014 Aug; 46(8):573-7. PubMed ID: 24934986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sero-prevalence and risk factors of brucellosis among suspected febrile patients attending a referral hospital in southern Saudi Arabia (2014-2018).
    Alkahtani AM; Assiry MM; Chandramoorthy HC; Al-Hakami AM; Hamid ME
    BMC Infect Dis; 2020 Jan; 20(1):26. PubMed ID: 31918671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A long-term survey of brucellosis: Is there any marker to predict the complicated cases?
    Kayaaslan B; Bastug A; Aydin E; Akinci E; But A; Aslaner H; Yetkin MA; Bodur H
    Infect Dis (Lond); 2016; 48(3):215-21. PubMed ID: 26568367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiological and clinical profiles of Saudi patients with hyperprolactinemia in a single tertiary care center.
    Mahzari M; Alhamlan KS; Alhussaini NA; Alkathiri TA; Al Khatir AN; Alqahtani AM; Masuadi EF
    Ann Saudi Med; 2022; 42(5):334-342. PubMed ID: 36252148
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prevalence, clinical features, predictive factors and investigations to screen for cancer in patients with inflammatory myositis. A case series from two tertiary care centers in Riyadh, Saudi Arabia.
    Aljohani G; Bin Awad EA; Alshahrani K; Alsaqar MM; Albogami B; Almotywee SH; Almaimouni H; Dirar AS; Alrashid A; Rajendram R; Masuadi E; Omair MA
    Saudi Med J; 2021 Jan; 42(1):100-104. PubMed ID: 33399178
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of human brucellosis.
    Solera J
    J Med Liban; 2000; 48(4):255-63. PubMed ID: 11214198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brucellosis in children: clinical observations in 115 cases.
    Shaalan MA; Memish ZA; Mahmoud SA; Alomari A; Khan MY; Almuneef M; Alalola S
    Int J Infect Dis; 2002 Sep; 6(3):182-6. PubMed ID: 12718832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and therapeutic features of brucellosis: An 11-year study at a tertiary care hospital in Riyadh, Saudi Arabia.
    Somily AM; Alahaideb A; Ridha A; Syyed S; Shakoor Z; Fatani A; Al-Subaie S; Barry M; Torchyan AA; BinSaeed AA; Alrabiaah A; Kambal AM; Senok A
    Trop Biomed; 2017 Dec; 34(4):977-982. PubMed ID: 33592968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Brucellosis in Chile: Description of a series of 13 cases].
    Olivares R; Vidal P; Sotomayor C; Norambuena M; Luppi M; Silva F; Cifuentes M
    Rev Chilena Infectol; 2017 Jun; 34(3):243-247. PubMed ID: 28991320
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinicopathologic characteristics and outcomes of patients with mycosis fungoides: A single tertiary center retrospective analysis in Saudi Arabia.
    Alghubaywi FA; Alharthi SA; Aldharman SS; Najjar RH; Aleissa MY; Aljarbou OZ; AlJasser MI; Almohideb MA
    Saudi Med J; 2023 Apr; 44(4):394-400. PubMed ID: 37062543
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A comparative therapeutic and multicenter trial of rifampicin and doxycycline versus streptomycin and doxycycline in human brucellosis].
    Solera J; Medrano F; Rodríguez M; Geijo P; Paulino J
    Med Clin (Barc); 1991 May; 96(17):649-53. PubMed ID: 1905372
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and Radiological Characteristics of Neuromyelitis Optica Spectrum Disorder: The Experience from Saudi Arabia.
    Algahtani H; Shirah B; Ibrahim B; Malik YA; Makkawi S
    Mult Scler Relat Disord; 2021 Jan; 47():102668. PubMed ID: 33307475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.